A method for production of red ginseng hydrolysis concentrate according to an embodiment of the present disclosure includes carrying out an enzyme reaction of red ginseng concentrate by adding an enzyme solution followed by addition of alcohol to prepare a mixture solution of red ginseng and alcohol, and centrifuging the prepared mixture solution of red ginseng and alcohol followed by concentration under reduced pressure of a supernatant separated by the centrifuge, and a red ginseng hydrolysis concentrate produced by the aforementioned process.

A method for production of red ginseng hydrolysis concentrate according to an embodiment of the present disclosure includes carrying out an enzyme reaction of red ginseng concentrate by adding an enzyme solution followed by addition of alcohol to prepare a mixture solution of red ginseng and alcohol, and centrifuging the prepared mixture solution of red ginseng and alcohol followed by concentration under reduced pressure of a supernatant separated by the centrifuge, and a red ginseng hydrolysis concentrate produced by the aforementioned process.

A method for production of red ginseng hydrolysis concentrate according to an embodiment of the present disclosure includes carrying out an enzyme reaction of red ginseng concentrate by adding an enzyme solution followed by addition of alcohol to prepare a mixture solution of red ginseng and alcohol, and centrifuging the prepared mixture solution of red ginseng and alcohol followed by concentration under reduced pressure of a supernatant separated by the centrifuge, and a red ginseng hydrolysis concentrate produced by the aforementioned process.

Phlorotannins with anti-viral properties, in particular those with a molecular mass of from about 1000 g/mol to about 3000 g/mol, are described. The phlorotannins may be obtained or obtainable as an extract from seaweed, and may be used in compositions or extracts as anti-viral agents. Methods for producing the extracts and their use for treating or preventing viral infections and for reducing or controlling a virus on a surface using the phlorotannins are also described.

Phlorotannins with anti-viral properties, in particular those with a molecular mass of from about 1000 g/mol to about 3000 g/mol, are described. The phlorotannins may be obtained or obtainable as an extract from seaweed, and may be used in compositions or extracts as anti-viral agents. Methods for producing the extracts and their use for treating or preventing viral infections and for reducing or controlling a virus on a surface using the phlorotannins are also described.

A composition comprises: (i) at least one fermented seaweed material; (ii) at least one fermented plant material: or (iii) a combination of at least one fermented seaweed material and at least one fermented plant material; and at least one lactic acid bacterial strain, for treating, alleviating, suppressing and/or preventing growth of a resistant organism.

A composition comprises: (i) at least one fermented seaweed material; (ii) at least one fermented plant material: or (iii) a combination of at least one fermented seaweed material and at least one fermented plant material; and at least one lactic acid bacterial strain, for treating, alleviating, suppressing and/or preventing growth of a resistant organism.

A composition is described for the prevention and treatment of skin diseases, in particular in the veterinary field. The composition of the invention includes a synergistic association of Lactobacilli and plant extracts, which has been shown to be significantly effective in supporting the functionality of the skin barrier and restoring homeostasis of microbial populations. In fact, the composition performs a direct action on the skin surface by preventing and contrasting skin alterations, promoting the balance of the microbiota, strengthening the immune system and carrying out antioxidant activity.

A composition is described for the prevention and treatment of skin diseases, in particular in the veterinary field. The composition of the invention includes a synergistic association of Lactobacilli and plant extracts, which has been shown to be significantly effective in supporting the functionality of the skin barrier and restoring homeostasis of microbial populations. In fact, the composition performs a direct action on the skin surface by preventing and contrasting skin alterations, promoting the balance of the microbiota, strengthening the immune system and carrying out antioxidant activity.

The present invention relates to a composition and methods comprising an amount of β-glucans and α-fucans, wherein the combination is synergistic to at least one of: increase growth of beneficial microbes and reduced levels of harmful microbes selected from E. coli or Salmonella in animal or human intestines, improve gut structure, reduce gut inflammation, improved nutrient digestibility, improve mineral absorption and growth performance, or reduce gut infection and inflammation.